Pricing Log in Create free account

Champions Oncology, Inc. (CSBR) vs Tenax Therapeutics, Inc. (TENX)

Champions Oncology, Inc. and Tenax Therapeutics, Inc. are both Biotechnology companies. Champions Oncology, Inc. and Tenax Therapeutics, Inc. are of similar size ($66.3M and $61.0M). Champions Oncology, Inc. grew revenue faster over the last twelve months: 6.65% against −70.8%. Tenax Therapeutics, Inc. has the higher net margin (0.00% vs −1.87%) and the higher return on invested capital (0.00% vs −626.2%). Across the 18 metrics below, Champions Oncology, Inc. leads on 9 and Tenax Therapeutics, Inc. on 9.

Valuation

Metric CSBR TENX Biotechnology median
P/E n/m n/m 10.26
P/S 1.10 242.52 9.18
P/B 14.93 0.73 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA 200.35 0.50 0.65
EV/Sales 1.03 (100.35) 8.98
Earnings yield (1.67%) (90.24%) (34.89%)
Free cash flow yield (9.18%) (55.21%) (24.52%)

Profitability

Metric CSBR TENX Biotechnology median
Gross margin 49.82% 0.00% 65.16%
Operating margin (1.68%) 0.00% 0.00%
Net margin (1.87%) 0.00% 0.00%
Free cash flow margin (10.08%) 0.00% 0.00%
Return on equity (28.38%) (59.80%) (50.12%)
Return on assets (3.56%) (57.02%) (45.60%)
Return on invested capital (626.23%) 0.00% 0.00%

Growth

Metric CSBR TENX Biotechnology median
Revenue growth (TTM) 6.65% (70.77%) 6.26%
EPS growth (last fiscal year) (124.24%) (16.52%) 29.88%
Revenue growth, 5-year CAGR 7.68% 0.79% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CSBR TENX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 1.03 15.07 4.89
Net debt to EBITDA (20.56) 1.73 1.01

Dividend

Metric CSBR TENX Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric CSBR TENX Biotechnology median
Market cap 66.26m 61.00m 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack